MAPT and Alzheimer disease: Currently, many hypotheses, including low levels of acetylcholine (AChE) and butyrylcholinesterase (BChE), aggregation of tau protein, and deposition of amyloid β-protein (Aβ) plaques, etc., have been proposed to explain the pathophysiology of AD (Wilson et al., 2012).